SFRP1‐dependent inhibition of the Wnt/β‐catenin pathway has been expounded to hinder the tumorigenesis and tumor metastasis in several cancers such as epithelial ovarian cancer34 and nasopharyngeal carcinoma.35 This evidence concerns the gene SFRP1 and neoplasm.